BACKGROUND: The purpose of this study was to assess the value of technetium 99m sestamibi gated single photon emission computed tomography (SPECT) in predicting the evolution of left ventricular volumes in patients treated successfully in the acute phase of a myocardial infarction (MI). METHODS AND RESULTS: Twenty-nine patients with acute MI and early percutaneous transluminal coronary angioplasty (PTCA) were included in this study. A rest Tc-99m sestamibi electrocardiography (ECG)-gated SPECT study was performed 21 +/- 5 days after PTCA. The myocardial perfusion index was calculated by use of a semiautomatic sectorial analysis. All patients had contrast ventriculography performed during the acute phase and 6 months later. The patients were separated into two groups according to the absence (group I, n = 21) or presence (group II, n = 8) of end-systolic enlargement. The perfusion index in the infarct sectors was -2.29 +/- 2.90 SD in group I and -6.40 +/- 2.85 SD in group II ( P < .01). With a cutoff value of -2.46 SD, the sensitivity and specificity of Tc-99m sestamibi SPECT for the prediction of end-systolic volume enlargement were 100% and 62%, respectively. When the functional data from ECG-gated acquisitions were added, specificity increased to 86%. CONCLUSIONS: Despite successful PTCA in the acute phase of MI, an increase in end-systolic volume was observed at 6 months in 28% of patients. Tc-99m sestamibi ECG-gated SPECT performed 3 weeks after the acute phase could predict this enlargement with a high accuracy.
BACKGROUND: The purpose of this study was to assess the value of technetium 99m sestamibi gated single photon emission computed tomography (SPECT) in predicting the evolution of left ventricular volumes in patients treated successfully in the acute phase of a myocardial infarction (MI). METHODS AND RESULTS: Twenty-nine patients with acute MI and early percutaneous transluminal coronary angioplasty (PTCA) were included in this study. A rest Tc-99m sestamibi electrocardiography (ECG)-gated SPECT study was performed 21 +/- 5 days after PTCA. The myocardial perfusion index was calculated by use of a semiautomatic sectorial analysis. All patients had contrast ventriculography performed during the acute phase and 6 months later. The patients were separated into two groups according to the absence (group I, n = 21) or presence (group II, n = 8) of end-systolic enlargement. The perfusion index in the infarct sectors was -2.29 +/- 2.90 SD in group I and -6.40 +/- 2.85 SD in group II ( P < .01). With a cutoff value of -2.46 SD, the sensitivity and specificity of Tc-99m sestamibi SPECT for the prediction of end-systolic volume enlargement were 100% and 62%, respectively. When the functional data from ECG-gated acquisitions were added, specificity increased to 86%. CONCLUSIONS: Despite successful PTCA in the acute phase of MI, an increase in end-systolic volume was observed at 6 months in 28% of patients. Tc-99m sestamibi ECG-gated SPECT performed 3 weeks after the acute phase could predict this enlargement with a high accuracy.
Authors: Leonardo Bolognese; Aleksandar N Neskovic; Guido Parodi; Giampaolo Cerisano; Piergiovanni Buonamici; Giovanni M Santoro; David Antoniucci Journal: Circulation Date: 2002-10-29 Impact factor: 29.690
Authors: Z Q Zhao; M Nakamura; N P Wang; J N Wilcox; S Shearer; R S Ronson; R A Guyton; J Vinten-Johansen Journal: Cardiovasc Res Date: 2000-02 Impact factor: 10.787
Authors: J C Maublant; B Citron; J Lipiecki; D Mestas; P Bailly; A Veyre; C de Riberolles; J Ponsonnaille Journal: Am Heart J Date: 1995-02 Impact factor: 4.749
Authors: R Medrano; R W Lowry; J B Young; D G Weilbaecher; L H Michael; I Afridi; Z X He; J J Mahmarian; M S Verani Journal: Circulation Date: 1996-09-01 Impact factor: 29.690
Authors: A Bailly; J Lipiecki; P Chabrot; A Alfidja; J M Garcier; S Ughetto; J Ponsonnaille; L Boyer Journal: Surg Radiol Anat Date: 2008-10-08 Impact factor: 1.246
Authors: Anne E Scott; Scott I K Semple; Thomas W Redpath; Graham S Hillis Journal: Eur Heart J Cardiovasc Imaging Date: 2013-01-12 Impact factor: 6.875